Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Reexamination Certificate
2006-10-17
2006-10-17
Kerr, Kathleen M. (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
C514S016700
Reexamination Certificate
active
07122625
ABSTRACT:
Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
REFERENCES:
patent: 99/61476 (1999-12-01), None
patent: 01/38347 (2001-05-01), None
patent: 01/38397 (2001-05-01), None
Bradley Michael F.
Haviv Fortuna
Abbott Laboratories
Corbin Johanna M.
Kerr Kathleen M.
Schnizer Holly
Steele Gregory W.
LandOfFree
Hexa-, hepta-, and octapeptides having antiangiogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hexa-, hepta-, and octapeptides having antiangiogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexa-, hepta-, and octapeptides having antiangiogenic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707171